Surgical or medical treatment of obesity-associated type 2 diabetes-an increasing clinical conundrum

被引：0

作者：

Jalleh, Ryan J. ^{[1
,2
,3
]}

Jones, Karen L. ^{[1
,2
,3
]}

Islam, Md Shahidul ^{[4
]}

Cai, Lu ^{[5
]}

Horowitz, Michael ^{[1
,2
,3
]}

机构：

[1] Univ Adelaide, Adelaide Med Sch, Level 5,AHMS Corner North Tce & George St, Adelaide 5000, Australia

[2] Univ Adelaide, Ctr Res Excellence Translating Nutr Sci Good Hlth, Adelaide, Australia

[3] Royal Adelaide Hosp, Endocrine & Metab Unit, Adelaide, SA 5000, Australia

[4] Univ KwaZulu Natal, Sch Life Sci, Dept Biochem, ZA-4000 Durban, South Africa

[5] Univ Louisville, Norton Childrens Hosp, Wendy Novak Diabet Inst, Pediat Res Inst,Div Endocrinol,Dept Pediat,Radiat, Louisville, KY 40202 USA

来源：

WORLD JOURNAL OF DIABETES | 2024年 / 15卷 / 10期

关键词：

Glucagon-like peptide-1; Glucagon-like peptide-1 receptor agonist; Obesity; Diabetes; Weight loss; Bariatric surgery; Metabolic surgery; Hypoglycemia; BARIATRIC SURGERY; DOUBLE-BLIND; LIRAGLUTIDE; PLACEBO; WEIGHT; GLP-1; GLIMEPIRIDE; MANAGEMENT; METFORMIN; EFFICACY;

D O I：

10.4239/wjd.v15.i10.2036

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this editorial, we comment on the article by He et al, specifically in relation to the efficacy of bariatric surgery vs glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy in the management of type 2 diabetes (T2D) associated with obesity. Bariatric surgery has now also been shown to be safe and effective in pre-teens and teenagers with obesity and T2D, but information on newer GLP-1RAs in these groups is predictably limited. In older individuals (age > 65 years), both bariatric surgery and GLP-1RA therapy improve cardiovascular outcomes. Bariatric surgery is not infrequently associated with post-operative postprandial hypoglycemia, which is not the case with GLP-1RAs and, paradoxically, there is evidence that GLP-1RAs may reduce both the frequency and severity of postprandial hypoglycemia. Comparative trials of the long-term efficacy of bariatric surgery and GLP-1RAs are indicated.

引用

页数：6

共 50 条

[41] Health state utilities associated with weight loss in type 2 diabetes and obesity [J].

Boye, Kristina S. ;

Matza, Louis S. ;

Stewart, Katie D. ;

Andrews, Haylee ;

Howell, Timothy A. ;

Stefanski, Adam ;

Malley, Karen G. ;

Ishak, K. Jack ;

Lando, Laura Fernandez .

JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) :14-25

[42] Medical treatment of type 2 diabetes mellitus: Recommendations of the Diabetes, Obesity and Nutrition Group of the Spanish Society of Internal Medicine [J].

Carrasco-Sanchez, F. J. ;

Fernandez-Rodriguez, J. M. ;

Ena, J. ;

Gomez-Huelgas, R. ;

Carretero-Gomez, J. .

REVISTA CLINICA ESPANOLA, 2021, 221 (02) :101-108

[43] Factors associated with gastrointestinal side effects after liraglutide treatment for type 2 diabetes [J].

Wu, Hao ;

Lu, Zongshi ;

Chen, Runyao ;

Cai, Quanfang ;

Wang, Miaomiao ;

Zhang, Liting ;

Zhu, Zhiming .

FRONTIERS IN ENDOCRINOLOGY, 2023, 14

[44] Clinical observation of gastric bypass in treatment of type 2 diabetes [J].

Pu Yong-dong ;

Li Jing-quan ;

Cao Zhi-yu ;

Wang Li ;

Hu Xiao ;

Dong Li-guo ;

Li Yue-min ;

Zhao Hua-zhou ;

Qin Rong ;

Yang Bo ;

He Jiao-miao ;

Wu You-jun ;

Wang Yi ;

Lu Gang ;

Zhang Bo ;

Wang Yue ;

Liu Wei-ping ;

Weng Jian-feng .

CHINESE MEDICAL JOURNAL, 2012, 125 (11) :1899-1902

[45] Surgical vs Lifestyle Treatment for Type 2 Diabetes [J].

Ludwig, David S. ;

Ebbeling, Cara B. ;

Livingston, Edward H. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (10) :981-982

[46] Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity [J].

Akira Sasaki ;

Koutaro Yokote ;

Takeshi Naitoh ;

Junji Fujikura ;

Karin Hayashi ;

Yushi Hirota ;

Nobuya Inagaki ;

Yasushi Ishigaki ;

Kazunori Kasama ;

Eri Kikkawa ;

Hidenori Koyama ;

Hiroaki Masuzaki ;

Takeshi Miyatsuka ;

Takehiro Nozaki ;

Wataru Ogawa ;

Masayuki Ohta ;

Shinichi Okazumi ;

Michio Shimabukuro ;

Iichiro Shimomura ;

Hitoshi Nishizawa ;

Atsuhito Saiki ;

Yosuke Seki ;

Nobuhiro Shojima ;

Motoyoshi Tsujino ;

Satoshi Ugi ;

Hiroaki Watada ;

Toshimasa Yamauchi ;

Takashi Yamaguchi ;

Kohjiro Ueki ;

Takashi Kadowaki ;

Ichiro Tatsuno .

Diabetology International, 2022, 13 :1-30

[47] Surgical Treatment of Type 2 Diabetes [J].

Blueher, Matthias .

DEUTSCHES ARZTEBLATT INTERNATIONAL, 2016, 113 (49) :825-826

[48] The postprandial dynamics of gastroduodenal zone hormones in patients with metabolic obesity associated or not associated with type 2 diabetes [J].

Kirienkova, E., V ;

Vasilenko, M. A. ;

Mironiuk, N., I ;

Skuratovskaia, D. A. ;

Zatolokin, P. A. ;

Litvinova, L. S. .

DIABETES MELLITUS, 2015, 18 (04) :22-27

[49] Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2023 [J].

ElSayed, Nuha A. ;

Aleppo, Grazia ;

Aroda, Vanita R. ;

Bannuru, Raveendhara R. ;

Brown, Florence M. ;

Bruemmer, Dennis ;

Collins, Billy S. ;

Hilliard, Marisa E. ;

Isaacs, Diana ;

Johnson, Eric L. ;

Kahan, Scott ;

Khunti, Kamlesh ;

Leon, Jose ;

Lyons, Sarah K. ;

Perry, Mary Lou ;

Prahalad, Priya ;

Pratley, Richard E. ;

Seley, Jane Jeffrie ;

Stanton, Robert C. ;

Gabbay, Robert A. .

DIABETES CARE, 2023, 46 :S128-S139

[50] Surgical and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in Class I Obese Patients: a Short-Term Outcome [J].

Bhandari, Mohit ;

Mathur, Winni ;

Kumar, Ravindra ;

Mishra, Arun ;

Bhandari, Mahak .

OBESITY SURGERY, 2017, 27 (12) :3267-3272

← 1 2 3 4 5 →